Changes in exploratory behavior as a measure of chronic central pain following spinal cord injury

Journal of Neurotrauma

Volumn 18, Issue 10, 2001, Pages 1091-1105

  Mills, Charles D ^a   Grady, James J ^a   Hulsebosch, Claire E ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Locomotor activity; Spinal cord injury; Spontaneous behavior

Indexed keywords

GABAPENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; CONTUSION; EVOKED RESPONSE; EXPLORATORY BEHAVIOR; LOCOMOTION; MALE; MEASUREMENT; NONHUMAN; RAT; SPINAL CORD INJURY; SURGICAL APPROACH;

ACETIC ACIDS; AMINES; ANALGESICS; ANIMALS; CHRONIC DISEASE; CYCLOHEXANECARBOXYLIC ACIDS; EXPLORATORY BEHAVIOR; GAMMA-AMINOBUTYRIC ACID; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MOTOR ACTIVITY; PAIN; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES;

EID: 0034781793     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/08977150152693773     Document Type: Article

References (74)

1. Behavioural effects of different intensities of formalin pain in rats
2. Gabapentin: A new agent for the management of epilepsy
3. Management of chronic pain
4. Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: A pilot study
5. Clinical management of chronic pain in spinal cord injury
6. Chronic changes in the response of cells in adult cat dorsal horn following partial deafferentation: The appearance of responding cells in a previously non-responding region
7. A sensitive and reliable locomotor rating scale for open field testing in rats
8. Intrathecal NMDA and non NMDA receptor antagonists reduce mechanical but not thermal allodynia in a rodent model of chronic central pain after spinal cord injury
9. Central dysesthesias syndrome in spinal cord injury patients
10. Gabapentin: Pharmacokinetics, efficacy, and safety
11. Comparative pharmacokinetics of the newer antielileptic drugs
12. Disturbances in cutaneous sensibility in patients with central pain caused by the spinal cord lesions of syringomyelia
13. Pain and depression in acute traumatic spinal cord injury: Origins of chronic problematic pain?
14. Chronic central pain after spinal cord injury
15. Spinal cord injury and anti-NGF treatment results in changes in CGRP density and distribution in the dorsal horn in the rat
16. Anti-convulsant action and long-term effects of gabapentin in the immature brain
17. Clinical characteristics of central (Dysesthetic) pain in spinal cord injury patients
18. Functional limiting dysesthetic pain syndrome among spinal cord injury patients: A cross sectional study
19. Plasticity in the spinal cord sensory map following peripheral nerve injury in rats
20. Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents
21. Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat
22. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel
23. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy
24. Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA
25. A monitored contusion model of spinal cord injury in the rat
26. Gabapentin potentiates the conductance increase induced by nipecotic acid in CA1 pyramidal neurons in vitro
27. Dorsal column lesions reverse the reduction of homecage activity in rats with pancreatitis
28. The effects of arterial blood gas values on lesion volumes in a graded rat spinal cord contusion model
29. Quantitation of sprouting of dorsal root axons
30. Sprouting of dorsal root axons
31. Rodent model of chronic central pain after spinal cord contusion injury
32. Long term efficacy of surgical cordotomy in intractable nonmalignant pain
33. Gabapentin increases GABA-induced depolarization in rat neonatal optic nerve
34. Sprouting of primary afferent fibers after spinal cord transection in the rat
35. Neutralizing intraspinal nerve growth factor blocks autonomic dysreflexia caused by spinal cord injury
36. Reduction in locomotor activity of arthritic rats as parameter for chronic pain: Effect of morphine, acetylsalicylic acid and citalopram
37. Characteristics of somatotopic organization and spontaneous neuronal activity in the region of the thalamic principal sensory nucleus in patients with spinal cord transection
38. Chronic pain associated with spinal cord injury
39. Spinal cord injuries - Clinical, functional, and emotional status
40. Evidence that reversed glutamate uptake contributes significantly to glutamate release following experimental injury to the rat spinal cord
41. Denervation induced intraspinal synaptogenesis of calcitonin gene-related peptide containing primary afferent terminals
42. Intraspinal sprouting of calcitonin gene-related peptide containing primary afferents after deafferentation in the rat
43. AIDA reduces glutamate release and attenuates mechanical allodynia after spinal cord injury
44. Pain in patients with spinal cord injury
45. A case of spinal cord injury-related pain with baseline rCBF brain SPECT imaging and beneficial response to gabapentin
46. Syringomyelia and syringobulbia
47. Central pain due to spinal cord and brain stem damage
48. Gabapentin inhibits excitatory synaptic transmission in the hyperalgesic spinal cord
49. Newer antiepileptic drugs. Towards an improved risk-benefit ratio
50. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy
51. Management of pain in persons with spinal cord injury
52. Psycho-social aspects of chronic pain in spinal cord injury
53. Spontaneous hyperactivity in the medial and intralaminar thalamic nuclei of patients with deafferentation pain
54. Chronic pain in a community-based sample of men with spinal cord injury: Prevalence, severity, and relationship with impairment, disability, handicap and subjective well-being
55. Gabapentin adjunctive therapy in neuropathic pain states
56. Syringomyelia and syringobulbia
57. Understanding chronic pain after spinal cord injury
58. Allodynia following traumatic spinal cord injury in the rat
59. Pain following spinal cord injury: Clinical features, prevalence, and taxonomy
60. The antiepileptic agent gabapentin (Neurontin) possess anziolytic-like and antinociceptive actions that are reversed by D-serine
61. Gabapentin (Neurontin), ineffective in normal animals, markedly reduces C-fiber evoked responses after inflammation
62. Gabapentin inhibits calcium currents in isolated rat brain neurons
63. Psychosocial factors in chronic spinal cord injury pain
64. Deafferentation syndromes in humans: A general discussion
65. Deafferentation and central pain
66. Gabapentin. Mechanisms of action
67. Spinal contusion induces changes in immunodensity of neuronal and glial glutamate transporters
68. Can mechanisms of central pain syndromes be investigated in animal models?
69. Pain following spinal cord injury: Animal models and mechanistic studies
70. Cordotomy: Assessment of its effectiveness and suggestions for its improvement
71. Long term alterations in the excitability of the flexion reflex produced by peripheral tissue injury in the chronic decerebrate rat
72. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states
73. Pain following spinal cord injury: Pathophysiology and central mechanisms